Mission
	Vision
	Environmental Policy
	Quality Policy
	Profile
	Milestones
	Offices

To manufacture and market pharmaceutical formulations and active pharmaceutical ingredients of requisite standards to comply with customer needs, enhance customer satisfaction and continuously improve the effectiveness of the Environmental Management System.

We shall be a responsible care company for the environment by promoting environment, complying applicable environmental regulations and prevention of pollution in all our operations, including planning for energy saving and conservation of natural resources.

To manufacture and market pharmaceutical formulations and active pharmaceutical ingredients of requisite standards to comply with customer needs, enhance customer satisfaction and continuously improve the effectiveness of the Quality Management System.

This shall be achieved by implementing the practices in processes and systems, updating and conforming to applicable regulatory requirements, continuous and dynamic improvements in quality of products and services.

Unichem brings to the customer a blend of modern-day research and nearly six decades of rich experience in the Indian pharmaceuticals industry. The Company was promoted by the late Mr. Amrut Mody, a pioneer in the Indian pharmaceuticals business.

Even though formulations account for a significant portion of Unichem's revenues, the Company also manufactures active pharmaceutical ingredients (API or bulk actives). The Company has prudently addressed relevant and growing therapeutic areas like gastro-intestinal, cardiovasculars, diabetes, psychaitry, neurology, anti-bacterials, anti-infectives and pain management, among others.

Unichem is headquartered in Mumbai with five manufacturing locations in Roha (Maharashtra), Goa, Ghaziabad (Uttar Pradesh), Pithampur (Madhya Pradesh) and Baddi (Himachal Pradesh). The Company's facilities enjoy credible certifications: for instance, the Goa plant has been approved by UK MHRA (earlier MCA), MCC (South Africa), WHO (Geneva) and TGA (Australia). The Baddi plant has been approved by UK MHRA and MCC (South Africa). The Company has received ISO 9001:2000 for all its plants and corporate office. Similarly the Company has received ISO 14001:2004 certificates for its formulation plants ( Goa, Ghaziabad and Baddi) and Corporate Office at Mumbai.

As a future-focused initiative. Unichem has expanded its Research and Development facility in Jogeshwari (Mumbai) to spearhead research in Novel Drug Delivery Systems (NDDS) and develop non-infringing routes for the manufacture of products directed at the regulated markets. The Company has also funded a collaborative research with the Indian Institute of Sciences, Bangalore. Unichem's growth strategy is fueled and backed by more than 2400 talented and motivated human resources.

	Unikare division launched which caters to Dermatology and Allied therapies
	US FDA cetification for Goa Plant Unichem Specialities Division Launched Acquisition of 100% stake in Niche Generics Limited, United Kingdom
	Set up of New Pharma Technology Development Center at GOA Baddi Unit II plant was commissioned Unichem acquired API manufacturing unit at Pithampur
	Restructuring of Unisearch & Launch of Unisearch CD Division
	Animal Healthcare division divested Subsidiaries in South Africa & Brazil established Modernization of Ghaziabad formulations plant
	Established Joint Venture in UK called Niche Generics Limited
	New R&D Centre set up at Mumbai. New Biosciences R&D Centre set up at Bangalore for research work in Bio-technology
	Corporate Vision till 2005 unfolded South African Health Authority Certifications for Goa and Baddi Plants Bonus Issue 1:1 UK MCA (MHRA) certification for Goa & Baddi Plants
	Modern Multipurpose Bulk Drug plant set up at Roha MOLECULAR GENERICS DIVN Launched
	BaaN ERP implemented
	Baddi formulations plant fully operational
	Goa formulations plant fully operational New Corporate office set up at Unichem Bhavan Jogeshwari, Mumbai.
	Merger of Unichem Exports Ltd. & Unisearch Ltd. with Unichem Laboratories Ltd
	Bonus Issue 1:2 First major capital infusion in the Company. Private Placement of shares @ Rs. 265 premium
	Right issue @ Rs.40/- per share
	Restructuring & transformation of the company inline with future growth strategies
	Entered Animal Health Care business
	Bonus Issue 1:2
	UNISEARCH Ltd. set up in Collaboration with Upjohn Unichem entered the anti-biotic segment - Ampoxin (Ampicillin & Cloxacillin combination) launched
	US FDA approval for Hydrochlorothiazide at Jogeshwari plant Anti-TB - Isoniazid, Rifampicin introduced in white tablet form for the first time in India - Anticox
	NEFEDIFINE - Unichem first to get clearance from Drug Authorities
	Bonus Issue 1:4 Roha Bulk Drug Plant established (Backward Integration)
	Fine Chemicals unit at Roha was set up
	Bonus Issue 1:7
	Unichem's Research Laboratory recognised for Phd work by Bombay University. Unichem's R&D Centre recognised by Department of Science & Technology
	Padma Bhushan awarded to Late Mr. Amrut Mody for his pioneering efforts in Indian Pharma Industry
	Backward Integration for manufacture of Anti-TB Drugs
	Bonus Issue 1:5
	Ghaziabad formulations plant setup
	Tie up with Uni Sankyo - Co-Marketing formulations
	Foreign Collaboration with UCB for bulk-drugs First Formulation plant at Jogeshwari Unichem became Public-Listed on BSE - Total Share Capital 44 lacs (October) OESTROGEN & Progestin combinations launched
	Unichem entered into Hormonal products UNIPROGESTIN launched
	First exports of Unichem
	Unichem was set up by Late Mr. Amrut Mody